Utah Medical Products | UTMD - Equity Capital And Reserves


Utah Medical Products reported $120.37M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
AngioDynamics USD 176.33M 2.52M Sep/2025
Baxter International USD 6.5B 296M Sep/2026
Cerus USD 64.22M 2.76M Dec/2025
CONMED USD 1.06B 18.53M Sep/2026
Cooper Companies USD 8.33B 89.1M Jun/2026
General Electric Aerospace USD 17.52B 118M Sep/2026
Integra LifeSciences USD 1.07B 23.24M Sep/2026
J&J USD 81.53B 3.44B Sep/2026
Medtronic USD 50.23B 160M Jun/2026
Merit Medical Systems USD 1.74B 64.75M Sep/2026
OraSure Technologies USD 317.78M 4.45M Jun/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 376.13M 10.73M Sep/2026
Stryker USD 23.99B 1.01B Jun/2026
Teleflex USD 3.49B 589.18M Sep/2026
Utah Medical Products USD 120.37M 1.1M Mar/2026
West Pharmaceutical Services USD 2.97B 22M Sep/2026